(1)
Strober, B. .; Imafuku, S. .; Paul, C.; Gooderham, M.; Spelman, L.; Seo, S. J.; Passeron, T.; Hoyt, K.; Colombo, M. J.; Banerjee, S.; Augustin, M.; Stein Gold, L.; Alexis, A. F.; Thaci, D.; Lebwohl, M.; Issa, N. T.; Cameron, M. C. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 4 Years in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. J of Skin 2024, 8, s407.